Urology and Bowel Management

Concepts

• urology, exploration devices
• bowel management
• faecal management products
• bowel
• urology
• fistula management
• chyme infusion management
• urinary catheters
• urine drainage bags
• catheters

Location

United Kingdom:

Description

Urinary catheters and accessories, External urinary catheters and sheaths, Urine drainage bags and accessories, Urine flow monitoring systems, Gels - medicated and non medicated, Bladder washout solutions, Urine collection devices, Enurisis alarms, Ultrasonic bacterial anti adhesion system for urinary catheters, Bowel and faecal management products, Enema tips and bags, stoma appliances and accessories, wound and fistula management, Urodynamic/surgery products, Skin care and protection, Chyme infusion management and Urethral Bulking Agents. It is anticipated that initial expenditure will be in the region of £28,500,000 to £30, 000,000 inc VAT in the first year of this framework agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement. The estimated value over the total framework agreement term is £120,000,000 inc VAT.

Lot Division

Renewal Options

It is anticipated that the Framework Agreement will have an initial term of 24 months (2 years) with an option to extend incrementally for a further two period of 12 months each (2 years). For the full 48 months. (4 years)

CPV Codes

• 33125000 - Urology, exploration devices
• 33141200 - Catheters
• 33141600 - Collector and collection bags, drainage and kits
• 33141615 - Bags for urine
• 33141240 - Catheter accessories
• 33141621 - Incontinence kit
• 33697100 - Enema preparations
• 33126000 - Stomatology devices
• 33141620 - Medical kits
• 33100000 - Medical equipments
• 33141118 - Wipes
• 33700000 - Personal care products

Indicators

• This is a one-off contract (no recurrence)
• Options are available.
• Renewals are not available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** Through continued market engagement, we recognise the need to review the Framework Agreement to reflect market changes to ensure that the NHS has access to the latest products and technologies . We also recognised that there could be issues with supply over the term of the Framework Agreement. We are, therefore, proposing that as part of the two 12 month extensions of the Framework Agreement for all Lots outlined within the ITT allows for reopening of Framework Agreement to allow any supplier (existing or new supplier) the opportunity to propose product innovations and development ideas that is made available on the market. This will be done through the range extension process only, this is to ensure that we can offer the latest products and associated technologies available to the NHS. These specifications have been developed to support the inclusion of product and/or technology which was not available at the time of the original tender. In relation to issues with supply (Supplier Resilience) of any of the product lines under any lot, we are also proposing the ability to reopen the Framework Agreement at any point during the term of the Framework Agreement. In an event where we identify that an existing supplier is unable to supply a particular product line (in any of the lots) to the participating authorities at any point during the term of the Framework Agreement, that they were originally awarded, we will have the ability to reopen the Framework Agreement in order to appoint a new supplier onto the Framework Agreement to provide such a product line. If existing suppliers are able to provide that particular product line, we will also have the right to reopen the Framework Agreement. As an awarded supplier, to one or more of these Lots, you will be consulted on any changes or additions proposed via innovation/development as well as any issues in regards to any Supplier Resilience. You will also be given the opportunity to also propose any product innovation or development and/or whether you have the availability to supply the products in an event that another existing supplier is unable to supply such a product line. In both instances of reopening the Framework Agreement (Product Innovation/development and Supplier Resilience) we will ensure that we will notify the market in line with the relevant advertising requirements at the time and via our eProcurement Platform. New suppliers and existing suppliers who propose or offer innovation/development or where there is a Supplier Resilience issue in any of the product lines within a Lot will have to meet specified requirements which include, and are not limited to, passing the product innovation MedTech Mandation route (if a product innovation/development proposal), adhering to the product specification and industry standards, ability to provide product support, and financial requirements before appointment to a Framework Agreement. If the Supplier or new supplier is successful in meeting the requirements then that supplier will be awarded a contract under the Framework Agreement either under the new Lot 19 – for any product Innovation/development or under the Lot in which the Supplier Resilience has occurred and not any other Lot. The Framework Agreement will include the following range of products: Urinary catheters and accessories, External urinary catheters and sheaths, Urine drainage bags and accessories, Urine flow monitoring systems, Gels - medicated and non-medicated, Bladder washout solutions, Urine collection devices, Enurisis alarms, Ultrasonic bacterial anti adhesion system for urinary catheters, Bowel and faecal management products, Enema tips and bags, stoma appliances and accessories, wound and fistula management, Urodynamic/surgery products, Skin care and protection, Chyme infusion management and Urethral Bulking Agents. It is anticipated that initial expenditure will be in the region of £28,500,000 to £30, 000,000 inc VAT in the first year.